Deals & Alliances Market Research

In this section you will find information products, including market research reports, on the following sector: Deals & Alliances

Stay up-to-date with new products added to this category

Results 1 - 100 of 547

previous 1 2 3 4 5 6 next

Title	Date	Price
Emerging Pharmaceutical Markets Globally	Apr 2008	£755
Distribution Agreements in Biopharma	Apr 2008	£1,210
Manufacturing & Supply Agreements in Biopharma	Apr 2008	£1,210
Nestle SA -Deals & Alliances Report	Feb 2008	£300
Neurochem Inc. -Deals & Alliances Report	Feb 2008	£300
Neurogen Corp. -Deals & Alliances Report	Feb 2008	£300
NPS Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300
Noven Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300
Nektar Therapeutics -Deals & Alliances Report	Feb 2008	£300
Nastech Pharmaceutical Company, Inc. -Deals & Alliances Report	Feb 2008	£300
Neose Technologies Inc. -Deals & Alliances Report	Feb 2008	£300
NitroMed Inc. -Deals & Alliances Report	Feb 2008	£300
Nuvelo Inc. -Deals & Alliances Report	Feb 2008	£300
Novavax, Inc. -Deals & Alliances Report	Feb 2008	£300
Novadel Pharma Inc. -Deals & Alliances Report	Feb 2008	£300
Novo Nordisk A -Deals & Alliances Report	Feb 2008	£300
Novartis AG -Deals & Alliances Report	Feb 2008	£300
Novozymes A -Deals & Alliances Report	Feb 2008	£300
Nanogen Inc. -Deals & Alliances Report	Feb 2008	£300
NexMed Inc. -Deals & Alliances Report	Feb 2008	£300
MGI Pharma Inc. -Deals & Alliances Report	Feb 2008	£300
Monsanto Co. -Deals & Alliances Report	Feb 2008	£300
Motorola Inc. -Deals & Alliances Report	Feb 2008	£300
Merge Technologies Inc. -Deals & Alliances Report	Feb 2008	£300
Merck & Co. Inc. -Deals & Alliances Report	Feb 2008	£300
Medicis Pharmaceutical Corp. -Deals & Alliances Report	Feb 2008	£300
Microsoft Corporation -Deals & Alliances Report	Feb 2008	£300
Misonix Inc. -Deals & Alliances Report	Feb 2008	£300
Myriad Genetics Inc. -Deals & Alliances Report	Feb 2008	£300
Mylan, Inc. -Deals & Alliances Report	Feb 2008	£300
Nabi Biopharmaceuticals -Deals & Alliances Report	Feb 2008	£300
North American Scientific Inc. -Deals & Alliances Report	Feb 2008	£300
Neurocrine Biosciences Inc. -Deals & Alliances Report	Feb 2008	£300
NeoPharm Inc. -Deals & Alliances Report	Feb 2008	£300
Neoprobe Corp. -Deals & Alliances Report	Feb 2008	£300
Nutrition 21 Inc. -Deals & Alliances Report	Feb 2008	£300
Nymox Pharmaceutical Corp. -Deals & Alliances Report	Feb 2008	£300
Omnicare Inc. -Deals & Alliances Report	Feb 2008	£300
Pharmacopeia, Inc. -Deals & Alliances Report	Feb 2008	£300
PDI Inc. -Deals & Alliances Report	Feb 2008	£300
PDL BioPharma Inc. -Deals & Alliances Report	Feb 2008	£300
Pfizer Inc. -Deals & Alliances Report	Feb 2008	£300
Phase Forward Inc. -Deals & Alliances Report	Feb 2008	£300
Procter & Gamble Co. -Deals & Alliances Report	Feb 2008	£300
Progen Pharmaceuticals Limited -Deals & Alliances Report	Feb 2008	£300
Progenics Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300
Koninklijke Philips Electronics NV -Deals & Alliances Report	Feb 2008	£300
Pharming Group N.V. -Deals & Alliances Report	Feb 2008	£300
Pharsight Corp. -Deals & Alliances Report	Feb 2008	£300
Phytopharm plc -Deals & Alliances Report	Feb 2008	£300
PerkinElmer Inc. -Deals & Alliances Report	Feb 2008	£300
Pall Corp. -Deals & Alliances Report	Feb 2008	£300
Pacific Biometrics Inc. -Deals & Alliances Report	Feb 2008	£300
Pressure BioSciences Inc. -Deals & Alliances Report	Feb 2008	£300
Poniard Pharmaceuticals, Inc. -Deals & Alliances Report	Feb 2008	£300
Orthofix International NV -Deals & Alliances Report	Feb 2008	£300
Omnicell Inc. -Deals & Alliances Report	Feb 2008	£300
Oncothyreon Inc -Deals & Alliances Report	Feb 2008	£300
Onyx Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300
Opko Health, Inc. -Deals & Alliances Report	Feb 2008	£300
Orchid Cellmark Inc. -Deals & Alliances Report	Feb 2008	£300
Oracle Corp. -Deals & Alliances Report	Feb 2008	£300
Oscient Pharmaceuticals Corp. -Deals & Alliances Report	Feb 2008	£300
OSI Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300
Osiris Therapeutics, Inc. -Deals & Alliances Report	Feb 2008	£300
OSI Systems, Inc. -Deals & Alliances Report	Feb 2008	£300
Osteotech Inc. -Deals & Alliances Report	Feb 2008	£300
OraSure Technologies Inc. -Deals & Alliances Report	Feb 2008	£300
Panacos Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300
Proteome Sciences plc -Deals & Alliances Report	Feb 2008	£300
Athersys, Inc. -Deals & Alliances Report	Feb 2008	£300
Angiotech Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300
Anika Therapeutics Inc. -Deals & Alliances Report	Feb 2008	£300
AngioDynamics Inc. -Deals & Alliances Report	Feb 2008	£300
Anadys Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300
Albany Molecular Research Inc. -Deals & Alliances Report	Feb 2008	£300
American Medical Systems Holdings Inc. -Deals & Alliances Report	Feb 2008	£300
Amylin Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300
Amgen Inc. -Deals & Alliances Report	Feb 2008	£300
Amarillo Biosciences Inc. -Deals & Alliances Report	Feb 2008	£300
AMAG Pharmaceuticals, Inc. -Deals & Alliances Report	Feb 2008	£300
Alexion Pharmaceuticals, Inc. -Deals & Alliances Report	Feb 2008	£300
Alseres Pharmaceuticals, Inc. -Deals & Alliances Report	Feb 2008	£300
Alpharx Inc. -Deals & Alliances Report	Feb 2008	£300
Alltracel Pharmaceuticals plc. -Deals & Alliances Report	Feb 2008	£300
Anesiva, Inc. -Deals & Alliances Report	Feb 2008	£300
Adventrx Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300
Air Products & Chemicals Inc. -Deals & Alliances Report	Feb 2008	£300
Aastrom Biosciences, Inc. -Deals & Alliances Report	Feb 2008	£300
Aspect Medical Systems, Inc. -Deals & Alliances Report	Feb 2008	£300
Arrowhead Research Corp. -Deals & Alliances Report	Feb 2008	£300
Arthrocare Corp. -Deals & Alliances Report	Feb 2008	£300
Array BioPharma, Inc. -Deals & Alliances Report	Feb 2008	£300
ArQule Inc. -Deals & Alliances Report	Feb 2008	£300
Arena Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300
Ariad Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300
Auriga Laboratories Inc. -Deals & Alliances Report	Feb 2008	£300
Aradigm Corp. -Deals & Alliances Report	Feb 2008	£300
Accuray Incorporated -Deals & Alliances Report	Feb 2008	£300
Advanced Plant Pharmaceuticals Inc. -Deals & Alliances Report	Feb 2008	£300